Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
about
Iron therapy in anaemic adults without chronic kidney diseaseIron deficiency in patients with heart failureIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.To the rescue: the role of intravenous iron in the management of severe anaemia in the peri-partum setting.The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study.Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.Heart failure highlights in 2012-2013.Ferric carboxymaltose: a review of its use in iron deficiency.Patient-reported outcomes in heart failure: existing measures and future uses.The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications.Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients.Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis.Iron deficiency beyond erythropoiesis: should we be concerned?Vitamin B12 and folate deficiency in chronic heart failure.Iron in kidney and heart failure: from theory to practice.Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure.Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study.Modern iron replacement therapy: clinical and pathophysiological insights.Iron status measurement in routine heart failure assessment: a call for action.Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).Intravenous Irons: From Basic Science to Clinical PracticeThe additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences
P2860
Q24187098-CA9B749E-ED90-41E6-A347-773332B0020BQ26822876-128FE937-2031-4013-AFAC-F0652C0347C0Q28088503-53694137-EA26-49A0-B7A4-1251D76ADFEFQ33700880-F819427E-37C6-42DB-A8F3-4F8E3DDF03ABQ34700903-CB5834A6-AFA4-4E63-9698-B4EF28133A0CQ35049204-A9D7DFE9-1EE9-4FBF-8844-92D9E5CF0EB3Q35549440-4CCA5D84-EB5E-4467-9DF1-18EDD864BB2CQ35627898-74D9602E-0139-48DC-A7BC-99ED44B21D35Q37411942-7B053C75-6BC0-4B55-9E73-3986F85AD3D8Q38181036-4FECC280-B2D9-4D21-B571-502DECAFDBF1Q38182010-7DC4D04A-AB2C-4F63-9C07-16DF00F16D00Q38271890-2A0AD0CE-1672-4E5E-81B9-93252F7BCFCAQ38363891-DCF80532-44DC-4413-85E2-325F1C9EB731Q38708011-38C89410-9D54-478A-AB32-E5BB361D5BF8Q39371536-9F500326-8920-4BCE-B623-47ACA75CEB1EQ39409288-C308B9FF-586F-4F64-8CCF-8F421204A227Q47141724-1BEDFBAC-47D2-4026-9061-A4C037F5DB08Q47415877-BB03D480-28ED-45CC-A1A0-7B8C1CAD2DA1Q48011055-541E29A4-3157-431C-A27A-34BCA231B24CQ48062370-6CA7411E-9FED-4EE4-95D3-831814D118F3Q48306942-756F161F-3DB2-47D9-BC41-711AEDCE45D7Q48716818-1670F1DD-FB1C-4E37-88E2-69D5FCD0E606Q49195291-3B863161-106A-4F1B-AE1D-BA4F6372F583Q49351942-E7E8ED06-2D2C-4A06-B722-ED8A513C50E4Q49487787-21D1774E-D1B0-4405-9DF2-57FFAC559368Q49972496-A888CE32-D3FF-4135-92B5-98FA7D5ACF8BQ57167424-37B48E97-E248-440F-B8DC-3E5407906A68Q57911412-73BCBFA6-3F44-4836-B9A1-71D3FAA574C3
P2860
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@en
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@nl
type
label
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@en
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@nl
prefLabel
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@en
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@nl
P2093
P2860
P50
P356
P1476
Intravenous ferric carboxymalt ...... analysis of the FAIR-HF trial.
@en
P2093
Barbara von Eisenhart Rothe
Claudio Mori
Dimitrios Farmakis
Giedrius Gaudesius
John Parissis
Josep Comin Colet
Nicola Greenlaw
P2860
P304
P356
10.1093/EURJHF/HFT099
P50
P577
2013-06-19T00:00:00Z